Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies:results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Details

Database :

OAIster

Journal :

Spanjaart , A M , Ljungman , P , de La Camara , R , Tridello , G , Ortiz-Maldonado , V , Urbano-Ispizua , A , Barba , P , Kwon , M , Caballero , D , Sesques , P , Bachy , E , Di Blasi , R , Thieblemont , C , Calkoen , F , Mutsaers , P , Maertens , J , Giannoni , L , Nicholson , E , Collin , M , Vaz , C P , Metafuni , E , Martinez-Lopez , J , Dignan , F L , Ribera , J M , Nagler , A , Folber , F , Sanderson , R , Bloor , A , Ciceri , F , Knelange , N , Ayuk , F , Kroger , N , Kersten , M J & Mielke , S 2021 , ' Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies : results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group ' , Leukemia , vol. 35 , no. 12 , pp. 3585-3588 .

Notes :

application/pdf, English

Publication Type :

Electronic Resource

Accession number :

edsoai.on1313639394

Document Type :

Electronic Resource